These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3874076)

  • 1. Biochemical characterization and purification of human B cell stimulatory factor (BSF).
    Schwarting R; Welte K; Chiorazzi N; Ralph P; Lane CL; Long C; Wang CY
    Eur J Immunol; 1985 Jun; 15(6):632-7. PubMed ID: 3874076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of lymphokines mediating B cell growth and differentiation from monoclonal anti-CD3 antibody-stimulated T cells.
    Sherris D; Stohl W; Mayer L
    J Immunol; 1989 Apr; 142(7):2343-51. PubMed ID: 2538506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial purification of murine B cell stimulatory factor (BSF)-1.
    Ohara J; Lahet S; Inman J; Paul WE
    J Immunol; 1985 Oct; 135(4):2518-23. PubMed ID: 3875657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
    Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
    J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A T-helper cell x Molt4 human hybridoma constitutively producing B-cell stimulatory and inhibitory factors.
    Rosén A; Uggla C; Szigeti R; Kallin B; Lindqvist C; Zeuthen J
    Lymphokine Res; 1986; 5(3):185-204. PubMed ID: 2943947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial biochemical characterization of IgG1-inducing factor.
    Sideras P; Bergstedt-Lindqvist S; Severinson E
    Eur J Immunol; 1985 Jun; 15(6):593-8. PubMed ID: 3874072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LPS-activated CBA/N mouse B cells respond to anti-Ig and a BSF-1-like factor.
    Howard M; Pesavento P; Stein P
    J Immunol; 1986 Jun; 136(12):4531-7. PubMed ID: 3486901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell-replacing factor in specific antibody responses to influenza virus by human blood B cells.
    Callard RE; Booth RJ; Brown MH; McCaughan GW
    Eur J Immunol; 1985 Jan; 15(1):52-9. PubMed ID: 2578400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCGFII activity on activated B cells of a purified murine T cell-replacing factor (TRF) from a T cell hybridoma (B151K12).
    Harada N; Kikuchi Y; Tominaga A; Takaki S; Takatsu K
    J Immunol; 1985 Jun; 134(6):3944-51. PubMed ID: 3872907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinction of B cell maturation factors from lymphokines affecting B cell growth and viability.
    Sherris DI; Sidman CL
    J Immunol; 1986 Feb; 136(3):994-8. PubMed ID: 3079808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical characterization of B cell stimulatory factors for lipopolysaccharide-preactivated B cell blasts: distinction from other known lymphokines.
    Ruuth E; Praz F; Lundgren E
    Lymphokine Res; 1988; 7(4):359-69. PubMed ID: 3264868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of B cell growth factor by normal human B cells.
    Jurgensen CH; Ambrus JL; Fauci AS
    J Immunol; 1986 Jun; 136(12):4542-7. PubMed ID: 3519772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human interferon-gamma acts as a B cell growth factor in the anti-IgM antibody co-stimulatory assay but has no direct B cell differentiation activity.
    Defrance T; Aubry JP; Vanbervliet B; Banchereau J
    J Immunol; 1986 Dec; 137(12):3861-7. PubMed ID: 3097134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immortalization of BGDF (BCGF II)- and BCDF-producing T cells by human T cell leukemia virus (HTLV) and characterization of human BGDF (BCGF II).
    Shimizu K; Hirano T; Ishibashi K; Nakano N; Taga T; Sugamura K; Yamamura Y; Kishimoto T
    J Immunol; 1985 Mar; 134(3):1728-33. PubMed ID: 2981920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and physicochemical characterization of murine T cell replacing factor (TRF).
    Takatsu K; Harada N; Hara Y; Takahama Y; Yamada G; Dobashi K; Hamaoka T
    J Immunol; 1985 Jan; 134(1):382-9. PubMed ID: 3871109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The requirement for high intracellular cyclic adenosine monophosphate concentrations distinguishes two pathways of B cell activation induced with lymphokines and antibody to immunoglobulin.
    Hoffmann MK
    J Immunol; 1988 Jan; 140(2):580-2. PubMed ID: 2826594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and partial characterization of human intracellular B cell growth factor.
    Sahasrabuddhe CG; Martin B; Maizel AL
    Lymphokine Res; 1986; 5(2):127-40. PubMed ID: 3486330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-efficiency purification and chemical characterization of B cell stimulatory factor-1/interleukin 4.
    Ohara J; Coligan JE; Zoon K; Maloy WL; Paul WE
    J Immunol; 1987 Aug; 139(4):1127-34. PubMed ID: 3497195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human growth factor for murine interleukin (IL)-9 responsive T cell lines: co-induction with IL-6 in fibroblasts and identification as LIF/HILDA.
    Van Damme J; Uyttenhove C; Houssiau F; Put W; Proost P; Van Snick J
    Eur J Immunol; 1992 Nov; 22(11):2801-8. PubMed ID: 1425908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and biologic characterization of lymphocyte regulatory molecules. VIII. Purification of interleukin 2 from a human T cell leukemia.
    Frank MB; Watson J; Mochizuki D; Gillis S
    J Immunol; 1981 Dec; 127(6):2361-5. PubMed ID: 6975318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.